JP Patent

JP7603662B2 — 特定のｖｍａｔ２阻害剤を重度腎障害の患者に投与するための方法

Assigned to ニューロクライン バイオサイエンシーズ，インコーポレイテッド · Expires 2024-12-20 · 1y expired

What this patent protects

Patent listed against valbenazine-tosylate.

Drugs covered by this patent

Patent Metadata

Patent number
JP7603662B2
Jurisdiction
JP
Classification
—
Expires
2024-12-20
Drug substance claim
No
Drug product claim
No
Assignee
ニューロクライン バイオサイエンシーズ，インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.